Valuation Cutia Therapeutics

Stocks

Market Closed - Hong Kong S.E. Other stock markets 04:08:03 2026-07-09 EDT			5-day change	1st Jan Change
2.690 ^HKD	+1.51%		-4.95%	-40.75%

05-07	Cutia Therapeutics Announces Drug Marketing Authorization for CU-30101 Localized Topical Lidocaine and Tetracaine Cream	CI
05-06	Cutia Therapeutics' Topical Anesthetic CU-30101 Approved in China	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025	2026	2027	2028
Market Cap ¹	3,030	2,120	1,482	848.3	-	-
Change	-	-30.05%	-30.06%	-42.78%	-	-
Enterprise Value (EV) ¹	2,471	2,055	1,469	916.9	848.3	686.6
Change	-	-16.83%	-28.53%	-37.57%	-7.49%	-19.06%
P/E	-1.04x	-4.72x	-3.96x	-5.1x	17.9x	2.25x
PBR	2.25x	2.17x	1.52x	1.84x	1.67x	1.21x
PEG	-0x	0.1x	0.1x	0.1x	-0x	0x
Capitalization / Revenue	22x	7.58x	4.41x	1.31x	0.72x	0.49x
EV / Revenue	18x	7.35x	4.37x	1.42x	0.72x	0.39x
EV / EBITDA	-4.96x	-4.89x	-5.69x	-7.72x	10.4x	1.54x
EV / EBIT	-4.58x	-4.46x	-4.89x	-6.4x	16.1x	2.81x
EV / FCF	-5.65x	-4.38x	-4.87x	-2.99x	-30x	11.1x
FCF Yield	-17.7%	-22.8%	-20.5%	-33.5%	-3.33%	8.98%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-9.6	-1.41	-1.03	-0.4581	0.1304	1.038
Distribution rate	-	-	-	-	-	-
Net sales ¹	137.6	279.6	336.2	645.9	1,180	1,738
EBITDA ¹	-498	-419.9	-257.9	-118.8	81.56	444.6
EBIT ¹	-538.9	-461.1	-300.1	-143.3	52.79	244.1
Net income ¹	-1,964	-433.8	-340.2	-145.7	44.25	330.6
Net Debt ¹	-559.6	-64.73	-13.8	68.7	-	-161.7
Reference price ²	9.967	6.653	4.080	2.334	2.334	2.334
Nbr of stocks (in thousands)	304,024	318,588	363,368	363,368	-	-
Announcement Date	3/27/24	3/24/25	3/24/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CUTIA THERAPEUTICS	-5.02x	1.4x	-7.61x	-	123M
ELI LILLY AND COMPANY	35.46x	12.91x	26.29x	0.56%	1,084B
JOHNSON & JOHNSON	28.11x	6.45x	17.52x	2.03%	634B
ABBVIE INC.	30.45x	7.46x	15.28x	2.72%	447B
ROCHE HOLDING AG	17.81x	4.43x	10.97x	2.99%	330B
ASTRAZENECA PLC	23.78x	4.98x	13.89x	1.75%	295B
NOVARTIS AG	21.66x	5.57x	13.46x	2.83%	285B
NOVO NORDISK A/S	14.26x	5.31x	10.9x	3.51%	218B
AMGEN INC.	24.07x	6.37x	11.22x	2.74%	199B
GILEAD SCIENCES, INC.	-48.15x	5.84x	32.48x	2.39%	169B
Average	14.24x	6.07x	14.44x	2.39%	366B
Weighted average by Cap.	24.23x	8.02x	18.60x	1.95%